Financials
- Market Capitalization 14.62 M
- Employee 7
- Founded 2004
- CEO N/A
- Website www.lexariabioscience.com
- Headquarter Nevada, United States
- FIGI BBG000JQHT18
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.34
ratio cours/chiffre d'affaires
22.59
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4708 | HIND Vyome Holdings, Inc. - Common Stock | 2.18 USD | -2.68% | -1.80% | +0.46% | -84.71% | 15.30 M USD | ||
| 4711 | QNCX Quince Therapeutics, Inc. - Common Stock | 19.98 USD | +15.83% | +12.63% | +2048.39% | +1003.87% | 16.28 M USD | ||
| 4723 | PASG Passage Bio, Inc. - Common Stock | 4.44 USD | -0.45% | -11.20% | -21.97% | -49.77% | 14.24 M USD | ||
| 4725 | CTXR Citius Pharmaceuticals, Inc. - Common Stock | 0.53 USD | -1.85% | -8.62% | -3.64% | -70.56% | 14.55 M USD |